Last Updated On 12/15/2023 3:04:33 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Amgen |
| Recipient: You |
| Company: crispr therapeutics |
| Recipient: You |
| Company: Intellia Therapeutics |
| Recipient: You |
| Company: Editas Medicine |
| Recipient: You |
| Company: Johnson & Johnson/Janssen |
| Recipient: You |
| Company: Natera |
| Recipient: You |
| Company: Novavax |
| Recipient: You |
| Company: Guardant Health AMEA |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
|
| Honoraria |
| Company: Seagen |
| Recipient: You |
| Company: Daiichi Sankyo/Lilly |
| Recipient: You |
| Company: Astellas Pharma |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Natera |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Natera Oncology |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| No Relationships to Disclose |
|
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Patent for a discovery in biomedical research |
| Recipient: An Immediate Family Member |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|